![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/337 | |
A61P 35/00 |
(11) | Number of the document | 2421562 |
(13) | Kind of document | T |
(96) | European patent application number | 10766565.5 |
Date of filing the European patent application | 2010-04-20 | |
(97) | Date of publication of the European application | 2012-02-29 |
(45) | Date of publication and mention of the grant of the patent | 2019-03-13 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CA2010/000618 |
Date | 2010-04-20 |
(87) | Number | WO 2010/121379 |
Date | 2010-10-28 |
(30) | Number | Date | Country code |
171040 P | 2009-04-20 | US |
(72) |
CASTAIGNE, Jean-Paul, CA
DEMEULE, Michel, CA
LAWRENCE, Betty, CA
|
(73) |
Angiochem Inc.,
4150 rue Ste. Catherine Ouest, Suite 490, Westmount, QC H3Z 2Y5,
CA
|
(54) | TREATMENT OF OVARIAN CANCER USING AN ANTICANCER AGENT CONJUGATED TO AN ANGIOPEP-2 ANALOG |
TREATMENT OF OVARIAN CANCER USING AN ANTICANCER AGENT CONJUGATED TO AN ANGIOPEP-2 ANALOG |